Search is Powered by Google
Cancer / Oncology News

DFG President Congratulates Harald Zur Hausen On The Nobel Prize For Medicine

Main Category: Cancer / Oncology
Also Included In: Cervical Cancer / HPV Vaccine
Article Date: 08 Oct 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:1 star

1 (1 votes)

Article Opinions: 0 posts

The President of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Professor Matthias Kleiner, has congratulated the Heidelberg cancer researcher, Professor Harald zur Hausen, on being awarded this year's Nobel Prize for Medicine. "The DFG, along with German science as a whole, is delighted that your pioneering research on cervical cancer has now been honoured with the highest accolade in science," said Kleiner in a letter of congratulations.

In the seventies and early eighties - among others, in a DFG-funded Collaborative Research Centre at the University of Freiburg -zur Hausen was already working on proof that human papillomaviruses, otherwise known as wart viruses, are a major cause of cervical cancer. He thus laid the foundations for better prevention and treatment of this form of cancer, which has become the third most common form to affect women, emphasised Kleiner.

The Nobel Prize, continued Kleiner, always testifies to the productive capacity of an entire scientific system. The fact that another German has been awarded this prize, after the physicist Theodor Hänsch was honoured in 2005, and both Gerhard Ertl, the chemist and long-term Vice President of the DFG, and the physicist Peter Grünberg were honoured last year, is impressive evidence of the quality of research and science in Germany. Zur Hausen's scientific career and, above all, his long-standing role as Chairman of the Board of the German Cancer Research Center (DKFZ) in Heidelberg indicate the successful interconnection between university and non-university research in Germany - something that has been widely promoted by the DFG.

Finally, Kleiner drew attention to the Nobel Prize recipient's equally groundbreaking efforts in the area of communicating scientific findings to society in general. With the DKFZ's Cancer Information Service (KID), zur Hausen has created a broadly used and recognised medium, which provides the general public with well-founded and useful information on the topic of cancer.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Dr. Eva-Maria Streier
Deutsche Forschungsgemeinschaft




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...